July 1, 2021 -- Bio-Rad Laboratories announced a partnership with South Korean molecular diagnostics company Seegene to develop and commercialize new diagnostic products for diagnosing infectious diseases.
Seegene will provide diagnostic tests for use on Bio-Rad's CFX96 Dx polymerase chain reaction (PCR) detection system, pending clinical development and clearance from the U.S. Food and Drug Administration, Bio-Rad said.
Seegene's assays offer multiplex real-time PCR detection and differentiation, with high sensitivity and specificity of up to seven targets in a single reaction, according to Bio-Rad.
When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.Yes, Keep Me Current